Our previous work showed that global CAV1 deficiency promotes CGD via the progression of hepatic lipid metabolism dysfunction and the upregulation of liver X receptor (LXR)-ABCG5/G8 signaling [6]. Here, ABCG5 is linked to chronic granulomatous disease.